Trial intelligence / Profile preview

Analgesic effects of buprenorphine and milnacipran in healthy volunteers

2012-002302-43Phase 2Completed

Sponsor
Dr. Reddy's Laboratories
Start
May 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of buprenorphine and milnacipran in Neuralgia and nociceptive pain, sponsored by Dr. Reddy's Laboratories. Primary endpoint: Safety and tolerability. Started May 2012; status: completed.

02

Drugs

buprenorphinemilnacipran
03

Conditions

Neuralgianociceptive pain

Beyond the preview

Go deeper on 2012-002302-43.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002302-43.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call